New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 26, 2013
15:47 EDTMDT, CRDC, GE, SYK, AETMedical device makers offsetting health tax with surcharges, WSJ says
Some medical device makers, facing a new 2.3% on device sales, are adding surcharges or price increases to offset the new tax that went int effect January 1, says the Wall Street Journal, adding that insurers too have attributed premium increases to the health law. Aetna (AET) CEO Mark Bertolini said in December that premiums for a subset of small business customers could "go up as much as 100 percent." Reference Link
News For MDT;CRDC;GE;SYK;AET From The Last 14 Days
Check below for free stories on MDT;CRDC;GE;SYK;AET the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
September 1, 2014
08:57 EDTGEGE Healthcare announces EU approval of Vizamyl
GE Healthcare announced that Vizamyl has received marketing authorization from the European Commission as a radiopharmaceutical medicinal product indicated for Positron Emission Tomography imaging of beta amyloid neuritic plaque density in the brains of adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease and other causes of cognitive impairment. Vizamyl is the only PET imaging tracer for detection of amyloid approved in Europe for visual interpretation of colour images and will be commercially available in selected European countries from early 2015, GE said.
August 31, 2014
12:50 EDTMDTEuropean Society of Cardiology to hold a conference
Subscribe for More Information
August 29, 2014
15:13 EDTGEQuirky drops out of bidding to buy appliance unit from GE, Bloomberg says
Subscribe for More Information
08:44 EDTGEQuirky drops out of bidding to buy appliance unit from GE, Bloomberg says
August 28, 2014
17:42 EDTMDTJ&J begins sales process for its medical device unit Cordis, WSJ says
Subscribe for More Information
09:05 EDTMDTMedtronic receives clearance for Shilla Growth Guidance System
Subscribe for More Information
August 27, 2014
11:41 EDTMDTMedtronic management to meet with Jefferies
Subscribe for More Information
10:05 EDTMDTMedtronic announces first implants in AdaptResponse CRT clinical trial
Medtronic announced the first implants in a clinical trial that will compare patient and healthcare system outcomes in heart failure patients who have cardiac resynchronization therapy devices with the AdaptivCRT feature enabled versus patients receiving standard CRT. The AdaptResponse trial will assess the superiority of the AdaptivCRT algorithm, which preserves normal heart rhythms and automatically adjusts to patients' needs to customize therapy. It is expected to enroll approximately 3K patients worldwide. The primary endpoint of the AdaptResponse trial is a combination of all-cause mortality and the rate of medical intervention for worsening heart failure. The trial also will examine the incidence of atrial fibrillation in enrolled patients. Other secondary endpoints will assess patient quality of life measures as well as cost-effectiveness of CRT devices with the AdaptivCRT feature relative to standard CRT. Patients will receive a CRT-pacemaker or CRT-defibrillator equipped with the AdaptivCRT algorithm, and will be randomized 1:1 to either treatment or control groups. Patients will be followed at three and six months after randomization, and then every six months until trial closure.
05:40 EDTMDTMedtronic sees impact of NGC Medical acquisition neutral to FY15 earnings
Subscribe for More Information
August 26, 2014
19:33 EDTMDTCovidien shareholder sues to block sale to Medtronic, Bloomberg reports
Subscribe for More Information
05:54 EDTMDTMedtronic acquires Sapiens SBS for $200M
Subscribe for More Information
August 25, 2014
10:03 EDTMDTMedtronic announces FDA approval of Viva CRT-P for heart failure or AV block
Subscribe for More Information
10:01 EDTGEHill-Rom reports settlement in patent infringement lawsuit with GE
Subscribe for More Information
07:34 EDTGEBristow Group appoints Akiri Chief Corporate Development officer
Subscribe for More Information
August 22, 2014
18:16 EDTGEGeneral Electric equipped 787 Dreamliner approved by regulators, WSJ says
Subscribe for More Information
18:05 EDTGEGeneral Electric awarded $123.4M government contract
General Electric Company, Lynn, Massachusetts, has been awarded a maximum $123,409,100 firm-fixed-price contract for compressor parts. This contract is a sole-source acquisition. This is a five-year base contract, with no option periods. Location of performance is Massachusetts, with an Aug. 21, 2019 performance completion date. Using military service is Army. Type of appropriation is fiscal 2014 Army working capital funds. The contracting activity is the Defense Logistics Agency Aviation, Redstone Arsenal, Alabama.
08:01 EDTGEGE CFS, VNG.co to support expansion of CNG fueling infrastructure
GE Capital Fleet Services announced an agreement with VNG.co, a national CNG fueling facility provider, to support the expansion of the CNG refueling infrastructure for light-duty fleet vehicles. Through the agreement with VNG, GE Capital Fleet Services’ customers will be able to take advantage of the increasing accessibility of CNG fueling stations, minimize overall fuel costs and meet financial and environmental objectives through the use of a lower cost, more stably priced, environmentally friendly and domestically sourced fuel.
August 20, 2014
08:47 EDTMDTMedtronic valuation attractive, says Morgan Stanley
Morgan Stanley said Medtronic's (MDT) valuation is attractive given pipeline execution, margin growth and shareholder returns, and expectations for the Covidien (COV) deal to go through. Shares are Overweight rated
08:11 EDTGEGE Healthcare Life Sciences announces new U.S. headquarters in MA
Subscribe for More Information
07:18 EDTMDTMedtronic shares have upside with or without deal, says Deutsche Bank
Deutsche Bank sees limited downside risk and significant upside potential for shares of Medtronic (MDT), with or without the pending Covidien (COV) acquisition. Deutsche says the Q1 results show improving trends and it keeps a Buy rating on Medtronic with an $85 price target.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use